Logo image of HSON

HUDSON GLOBAL INC (HSON) Stock Fundamental Analysis

NASDAQ:HSON - Nasdaq - US4437872058 - Common Stock - Currency: USD

8.59  +0.18 (+2.14%)

Fundamental Rating

4

Overall HSON gets a fundamental rating of 4 out of 10. We evaluated HSON against 82 industry peers in the Professional Services industry. No worries on liquidiy or solvency for HSON as it has an excellent financial health rating, but there are worries on the profitability. HSON is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year HSON has reported negative net income.
In the past year HSON has reported a negative cash flow from operations.
In multiple years HSON reported negative net income over the last 5 years.
In multiple years HSON reported negative operating cash flow during the last 5 years.
HSON Yearly Net Income VS EBIT VS OCF VS FCFHSON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

With a Return On Assets value of -6.82%, HSON is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
HSON's Return On Equity of -9.19% is on the low side compared to the rest of the industry. HSON is outperformed by 71.95% of its industry peers.
Industry RankSector Rank
ROA -6.82%
ROE -9.19%
ROIC N/A
ROA(3y)1.66%
ROA(5y)1.52%
ROE(3y)2.74%
ROE(5y)2.57%
ROIC(3y)N/A
ROIC(5y)N/A
HSON Yearly ROA, ROE, ROICHSON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a decent Gross Margin value of 50.87%, HSON is doing good in the industry, outperforming 63.41% of the companies in the same industry.
In the last couple of years the Gross Margin of HSON has grown nicely.
HSON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
HSON Yearly Profit, Operating, Gross MarginsHSON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

HSON does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSON has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSON has less shares outstanding
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HSON Yearly Shares OutstandingHSON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
HSON Yearly Total Debt VS Total AssetsHSON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -7.27, we must say that HSON is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -7.27, HSON is not doing good in the industry: 92.68% of the companies in the same industry are doing better.
HSON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -7.27
ROIC/WACCN/A
WACC9.02%
HSON Yearly LT Debt VS Equity VS FCFHSON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

HSON has a Current Ratio of 3.22. This indicates that HSON is financially healthy and has no problem in meeting its short term obligations.
HSON's Current ratio of 3.22 is amongst the best of the industry. HSON outperforms 86.59% of its industry peers.
HSON has a Quick Ratio of 3.22. This indicates that HSON is financially healthy and has no problem in meeting its short term obligations.
HSON has a Quick ratio of 3.22. This is amongst the best in the industry. HSON outperforms 87.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 3.22
HSON Yearly Current Assets VS Current LiabilitesHSON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

HSON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -229.73%.
The Revenue has decreased by -9.29% in the past year.
Measured over the past years, HSON shows a quite strong growth in Revenue. The Revenue has been growing by 8.35% on average per year.
EPS 1Y (TTM)-229.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.89%
Revenue 1Y (TTM)-9.29%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-5.98%

3.2 Future

HSON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.07% yearly.
HSON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.06% yearly.
EPS Next Y63.85%
EPS Next 2Y69.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.63%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HSON Yearly Revenue VS EstimatesHSON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
HSON Yearly EPS VS EstimatesHSON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HSON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 6.33, the valuation of HSON can be described as very cheap.
Based on the Price/Forward Earnings ratio, HSON is valued cheaper than 95.12% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.27. HSON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.33
HSON Price Earnings VS Forward Price EarningsHSON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HSON Per share dataHSON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HSON's earnings are expected to grow with 69.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.07%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUDSON GLOBAL INC

NASDAQ:HSON (6/24/2025, 11:28:42 AM)

8.59

+0.18 (+2.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners66.05%
Inst Owner Change-1.59%
Ins Owners14.5%
Ins Owner Change0.24%
Market Cap23.62M
Analysts82.86
Price Target19.38 (125.61%)
Short Float %0.14%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-142.03%
Min EPS beat(2)-261.52%
Max EPS beat(2)-22.55%
EPS beat(4)0
Avg EPS beat(4)-161.66%
Min EPS beat(4)-261.52%
Max EPS beat(4)-22.55%
EPS beat(8)1
Avg EPS beat(8)-334.82%
EPS beat(12)2
Avg EPS beat(12)-239.79%
EPS beat(16)5
Avg EPS beat(16)-171.92%
Revenue beat(2)0
Avg Revenue beat(2)-7.4%
Min Revenue beat(2)-11.38%
Max Revenue beat(2)-3.43%
Revenue beat(4)0
Avg Revenue beat(4)-8.8%
Min Revenue beat(4)-20.37%
Max Revenue beat(4)-0.04%
Revenue beat(8)0
Avg Revenue beat(8)-8.74%
Revenue beat(12)1
Avg Revenue beat(12)-7.83%
Revenue beat(16)5
Avg Revenue beat(16)-3.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-157.14%
EPS NY rev (1m)-330.77%
EPS NY rev (3m)-188.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.33
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)1.36
Fwd EY15.79%
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS50.19
BVpS14.35
TBVpS11.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -9.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.87%
FCFM N/A
ROA(3y)1.66%
ROA(5y)1.52%
ROE(3y)2.74%
ROE(5y)2.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.51%
GM growth 5Y1.51%
F-Score6
Asset Turnover2.6
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.2%
Cap/Sales 0.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.22
Quick Ratio 3.22
Altman-Z -7.27
F-Score6
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)14.77%
Cap/Depr(5y)20.42%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-229.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.89%
EPS Next Y63.85%
EPS Next 2Y69.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.29%
Revenue growth 3Y-6.11%
Revenue growth 5Y8.35%
Sales Q2Q%-5.98%
Revenue Next Year-3.63%
Revenue Next 2Y2.06%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-128.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.18%
OCF growth 3YN/A
OCF growth 5YN/A